{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-24-000057","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.232096+00:00","generated_at":"2026-06-01T04:34:39.212065+00:00","sec_items":["5.02","5.07"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Pacira BioSciences director Gary Pace to retire June 30; consulting deal; shareholder votes","bullets":["Director Gary Pace to retire from Board June 30, 2024; no disagreement with company.","Consulting agreement amendment: one-year term from July 2024 to June 2025, $3,200/quarter for up to 8 hours.","Shareholders elected Class I directors: Laura Brege, Mark Froimson, Mark Kronenfeld, Michael Yang.","KPMG ratified as independent auditor for FY 2024 with ~43.9M for, 0.2M against.","Advisory say-on-pay vote passed with ~37.2M for, 4.1M against, 2.7M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-24-000057","json":"https://secwatch.observer/filing/0001396814-24-000057.json","markdown":"https://secwatch.observer/filing/0001396814-24-000057.md","text":"https://secwatch.observer/filing/0001396814-24-000057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000057/0001396814-24-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000057/pcrx-20240611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:34:39.212065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d950d3e918","claim":"Gary Pace departed as Director at Pacira BioSciences, Inc..","evidence_excerpt":"On June 11, 2024, Gary Pace notified the Board of Directors (the “Board”) of Pacira BioSciences, Inc. (the “Company”) of his intent to retire from the Board, effective June 30, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000057/0001396814-24-000057-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}